FIL Ltd
SEC CIK 318989 · EDGAR
Most active insiders at BCAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $4.80M | — |
| 2 | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | — | $4.60M |
| 3 | Mazumdar Claire | CEO, Dir | — | $4.06M |
| 4 | Hyep Ivan | CFO | — | $3.24M |
| 5 | Raben David | Chief Medical Off | — | $1.15M |
| 6 | Meisner Lara | CLO | — | $498.7K |
FIL Ltd made no open-market trades at BCAX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-09-18 | 2024-09-16 | BCAX | Bicara Therapeutics Inc. | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +1.01M | 54.1K | New | — |
| DMI | 2023-02-09 | 2023-02-07 | GPCR | Structure Therapeutics Inc. | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +6.47M | 494.0K | New | — |
| DI | 2021-10-28 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +218.7K | 218.7K | New | — |
Purchase Sale Sale after option exercise All abbreviations